Blume-Jensen Peter Insider Trading Activity (ACRV)

Profile

Peter Blume-Jensen is the President and Chief Executive Officer of Acrivon Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company. Based on SEC filings with CIK 0001950499, the most recent filing date is January 16, 2026, and the record shows eight filings with no reported purchases or sales attributed to him.

Role	Insider
Notability	35/100

Board memberships

Acrivon Therapeutics, Inc.

Awards & honors

Leading Acrivon Therapeutics’ strategy and executive leadership for its oncology programs
Overseeing development of ACR-368 (prexasertib) within the company’s pipeline
Advancing a proteomics-based patient responder platform to guide oncology therapies

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-26	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	13.7K	$1.79	$25K
2026-05-20	ACRV	Acrivon Therapeutics, Inc.	A — Grant or award	72.7K	$0.00
2026-05-20	ACRV	Acrivon Therapeutics, Inc.	A — Grant or award	180.1K	$0.00
2026-05-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	490	$1.92	$941
2026-05-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	1.3K	$1.92	$2K
2026-02-24	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	14.3K	$1.53	$22K
2026-02-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	579	$1.63	$944
2026-02-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	1.3K	$1.63	$2K
2026-01-16	ACRV	Acrivon Therapeutics, Inc.	P — Open-market purchase	49.0K	$1.68	$82K
2025-08-21	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	19.9K	$1.32	$26K
2025-08-14	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	490	$1.39	$681
2025-08-14	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	59.8K	$1.39	$83K
2024-11-25	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	19.9K	$6.44	$128K
2024-11-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	490	$7.92	$4K
2024-11-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	59.8K	$7.92	$473K

Frequently Asked Questions

Who is Blume-Jensen Peter?

How many SEC Form 4 filings has Blume-Jensen Peter submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Blume-Jensen Peter been buying or selling stock?

Recorded transactions: 1 open-market purchases ($82K) and 0 open-market sales () across all tracked filings.

Where can I see all of Blume-Jensen Peter's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Blume-Jensen Peter — SEC Form 4 Insider Trading Activity

Summary